F.D.A. Rejects Closely Watched Lung Cancer Drug From China

CitrixNews Staff

· November 15, 2026 at 8:33 PM

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

Originally reported by New York Times. Read the full story at the original source.

So far, President Trump has indicated that he does not plan to press the Chinese leader about U.S. intelligence findings...

Rep.-elect Dan Koh (D-Mass.) on Sunday blamed President Trump for blocking more than $1 trillion in Biden-era funding fo...

A federal prosecutor in Texas warned Sen. Elizabeth Warren (D-Mass.) on Sunday of potential legal consequences over her ...

President Trump said on Sunday that the Interior Department will appeal a court ruling which barred the Trump administra...

Related Articles